Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine/Adrenalin Wound Infiltration During Cesarean Section
NCT03395912Completed
- Sponsor
- Emek Medical Center
- Start
- Jan 2018
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection and epinephrine in postoperative pain (2 arms), sponsored by Emek Medical Center. Primary endpoint: Self reported pain intensity up to 24 hours. Started Jan 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03395912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395912.